For research use only. Not for therapeutic Use.
Bisdemethoxycurcumin (BDMC) is a natural demethoxy derivative of curcumin. It is a potent activator of macrophage phagocytosis, interacting with 1α,25-<wbr></wbr>dihydroxy vitamin D<sub>3</sub> to stimulate amyloid-<wbr></wbr>β clearance by macrophages (optimal stimulation at 100 nM BDMC). More stable than curcumin in physiological media, BDMC suppresses proliferation in cancer cells. It down-<wbr></wbr>regulates the transcriptional coactivator p300, suppressing the Wnt/β-<wbr></wbr>catenin pathway, and inhibits LPS induction of iNOS expression.
Catalog Number | R022612 |
CAS Number | 24939-16-0 |
Synonyms | 1,7-Bis(p-hydroxyphenyl)-1,6-heptadiene-3,5-dione; Bis(4-hydroxycinnamoyl)methane; Bisdemethoxycucurmin; p,p’-Dihydroxydicinnamoylmethane |
Molecular Formula | C19H16O4 |
Purity | ≥95% |
Target | Disease Research Fields |
Storage | -20°C |
IUPAC Name | (1E,6E)-1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione |
InChI | InChI=1S/C19H16O4/c20-16-7-1-14(2-8-16)5-11-18(22)13-19(23)12-6-15-3-9-17(21)10-4-15/h1-12,20-21H,13H2/b11-5+,12-6+ |
InChIKey | PREBVFJICNPEKM-YDWXAUTNSA-N |
SMILES | C1=CC(=CC=C1C=CC(=O)CC(=O)C=CC2=CC=C(C=C2)O)O |